Trial NCT02519842

View at ClinicalTrials.gov 
Org. Study IDs: 0517-044
Secondary IDs: 2014-001783-34 MK-0517-044

Last trial update was posted on 2019-03-15

MeSH Interventions

Aprepitant Dexamethasone Fosaprepitant Ondansetron Serotonin 5-HT3 Receptor Antagonists

MeSH Conditions

Nausea Vomiting

Other Conditions

Chemotherapy-induced Nausea and Vomiting

Stopping Reasons

Further data are no longer required to support an application for use in pediatric patients. The decision to terminate was not based on any new safety findings

Limitations And Caveats

Enrollment was terminated early because the data were not necessary to support a claim in pediatric participants and not due to safety concerns. The last participant enrolled on 2016-08-05 and enrolled participants were active until study completion.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID